Gupta downplays safety risks in treatments, and was criticized for his reporting on Vioxx, a pain medication that was withdrawn from the market in 2004 because it causes heart attacks.
For dying patients with no therapy that is working, compassionate use programs exist to provide drugs in phase II or III clinical trials when the patient was ineligible to participate in the trial.
Pfizer Inc. is in talks to acquire rival drug maker Wyeth in a deal that could be valued at more than $60 billion, said people familiar with the matte...
Drug-company corruption of American medicine is of course not news. What is news is that such corruption has become so egregious, so transparent, and so embarrassing.
The FDA needs to admit that it is currently powerless over the industry it is supposed to be regulating; it has let Big Pharma take over and become dependent on drug company money.
Mainstream healthcare in America has been abducted by the pharmaceutical and insurance companies. As profits have moved to the center stage, patient c...
A new draft global trade treaty may interfere with fair use of copyrighted materials, require Internet Service Providers (ISPs) to monitor all consume...
Doctors know as much about nutrition, diet, supplements and exercise as Portuguese language professors know about agility training for the Portuguese Water Dog.
The corruption of psychiatry by Big Pharma has resulted in the suppression of effective treatment options and has marginalized courageous, innovative, and non-corrupt psychiatrists.
At the same time that federal lawmakers are proclaiming that pot has no medical value, Big Pharma is in a frenzy to bring dozens of new, cannabis-based medicines to market.
MUMBAI (Reuters) - Pfizer may bid for Ranbaxy Laboratories, countering a $4.6 billion (2.4 billion pound) offer by Japan's Daiichi Sankyo for the Indi...
Pfizer's search for new drugs took another hit when the company halted a late-stage trial of an experimental medicine to treat metastatic skin cancer....
Under criticism that its ads are misleading, Pfizer said Monday that it would cancel a long-running advertising campaign using the artificial heart pi...
The pharmaceutical industry has been a frequent target in the current presidential campaign, but that hasn't stopped it from continuing to aggressivel...
This storyline persists despite the fact that government research has repeatedly shown that most adults and children with mental health issues don't g...
A patent dispute over the heartburn drug Protonix escalated Monday when Wyeth said it will sue to recover lost profits from sales of Teva Pharmaceutic...
The drugmaker Eli Lilly and Co. said Tuesday Sidney Taurel will retire as chief executive on March 31 after nearly a decade in the post and will step ...
Novartis AG will cut 2,500 jobs worldwide by 2010 in an attempt to save $1.6 billion, the drug maker said Thursday.
The company said it would take a ...
Over the next few years, the pharmaceutical business will hit a wall.
Some of the top-selling drugs in industry history will become history as patent...
US drugmaker Bristol-Myers Squibb says it will cut its 43,000-strong workforce by 10% and close half of its 27 manufacturing plants to save $1.5bn.
T...